Internal Medicine, Pulmonary Disease · Caguas, PR
NPI
1295802486
Since 2006
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
Hima Plaza I, 500 Degetau Ave Suite 503-504
Caguas, PR, 00725
Phone (787) 703-1525
Groups this clinician bills Medicare through
Medicare paid, 2024
$10K
205 services
Medicare patients, 2024
32
Average age 73
Drug cost, 2024
$1.3M
13,014 prescriptions
Company payments, 2025
$236
From 4 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Juan J Candelario Lanza was code 94060 (pulmonary function testing), 71 times for 32 patients. In total Juan J Candelario Lanza billed 205 services in 7 codes, and Medicare paid $10K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-03-28.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 94060 Pulmonary Function Testing | Office | 71 | 32 | $29.21 | $2,074 |
| 99213 Office E&M - Established | Office | 66 | 31 | $68.55 | $4,524 |
| 94727 Pulmonary Function Testing | Office | 24 | 22 | $33.80 | $811 |
| 94729 Pulmonary Function Testing | Office | 24 | 22 | $41.28 | $991 |
By year: 2022 $17K for 325 services; 2023 $12K for 235 services; 2024 $10K for 205 services.
Medicare prescription drug claims, 2024
In 2024, the drug Juan J Candelario Lanza prescribed most often to Medicare patients was Fluticasone Propionate, with 2,543 prescriptions and refills. In total Juan J Candelario Lanza wrote 13,014 Medicare prescriptions that cost $1.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Fluticasone Propionate Generic | 2,543 | 2,745 | 655 | $36K |
| Albuterol Sulfate Hfa Albuterol Sulfate | 2,432 | 2,508 | 557 | $103K |
| Montelukast Sodium Generic | 1,752 | 1,978 | 382 | $14K |
| Levocetirizine Dihydrochloride Generic | 676 | 714 | 176 | $7,011 |
| Spiriva Respimat Tiotropium Bromide | 614 | 620 | 128 | $329K |
| Methylprednisolone Generic | 415 | 415 | 285 | $1,850 |
| Wixela Inhub Fluticasone Propion/Salmeterol | 402 | 412 | 95 | $63K |
| Arnuity Ellipta Fluticasone Furoate | 335 | 339 | 87 | $95K |
| Budesonide-Formoterol Fumarate Budesonide/Formoterol Fumarate | 331 | 345 | 79 | $84K |
| Famotidine Generic | 321 | 363 | 106 | $2,643 |
| Fluticasone Propionate Hfa Fluticasone Propionate | 319 | 347 | 97 | $85K |
| Azelastine Hcl Generic | 309 | 371 | 87 | $7,444 |
| Azithromycin Generic | 197 | 197 | 178 | $2,748 |
| Asmanex Hfa Mometasone Furoate | 170 | 179 | 54 | $21K |
| Stiolto Respimat Tiotropium Br/Olodaterol Hcl | 159 | 159 | 30 | $78K |
Brand drugs: 4,324 claims; generic drugs: 8,690 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Juan J Candelario Lanza $236 ($236 in general payments such as food, travel and fees) from 4 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $164.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.